[EN] PKM2 MODULATORS AND METHODS FOR THEIR USE<br/>[FR] MODULATEURS DE PKM2 ET PROCÉDÉS POUR LES UTILISER
申请人:TOLERO PHARMACEUTICALS INC
公开号:WO2014062838A2
公开(公告)日:2014-04-24
Compounds having activity as PKM2 activators are disclosed. The compounds have the following structure (I): including stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R3, R4, R5 and R6 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.